Investment
Features
FeesSafety
Academy
More
Pluang+

Toll Brothers at Marsh Harbor wins Best of Show at 2026 Northeast Florida Parade of Homes.

Market News
10 Jun 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

Toll Brothers' luxury community at Marsh Harbor in Ponte Vedra, Florida, received the Best of Show and Gold awards at the 2026 Northeast Florida Parade of Homes. The awards recognize excellence in home building, design, and craftsmanship, highlighting the community's sophisticated architecture and curated interiors. Homes start at $1.67 million, offering personalized luxury living with expansive floor plans and indoor/outdoor spaces. This accolade underscores Toll Brothers' commitment to quality and innovation in luxury homebuilding.

More News

Reactive hot melt adhesives market to reach $4.29B by 2035, driven by automotive and furniture demand.

Reactive hot melt adhesives market to reach $4.29B by 2035, driven by automotive and furniture demand.

The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...

Market News
Bullish
36 minutes ago
Global automotive microcontrollers market to reach $34.31B by 2035, driven by ADAS, electrification, and software-defined vehicles.

Global automotive microcontrollers market to reach $34.31B by 2035, driven by ADAS, electrification, and software-defined vehicles.

The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...

Market News
Bullish
4 hours ago
Xenon Pharmaceuticals advances with strong Phase 3 epilepsy data, eyeing NDA filing in 2026.

Xenon Pharmaceuticals advances with strong Phase 3 epilepsy data, eyeing NDA filing in 2026.

Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...

Market News
Bullish
4 hours ago
Microsoft stock drops 30% despite strong AI-driven growth and solid earnings.

Microsoft stock drops 30% despite strong AI-driven growth and solid earnings.

Microsoft shares have fallen about 30% from their peak last year, trading near $395, despite showing strong earnings growth of around 17% and robust AI integration in its products. The market appears to undervalue Microsoft’s AI advancements, with Of...

Market News
Bullish
4 hours ago
Nvidia launches Cosmos 3 Edge AI model and expands AI partnerships in Japan's industry and healthcare sectors

Nvidia launches Cosmos 3 Edge AI model and expands AI partnerships in Japan's industry and healthcare sectors

Nvidia introduced Cosmos 3 Edge, a new AI model designed for robots and vision AI agents to navigate physical environments in real time. The company is expanding its AI ecosystem in Japan by partnering with major local firms like Fujitsu, Hitachi, an...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App